跳至主要内容
临床试验/NCT02865837
NCT02865837已完成不适用

Effect of Bladder Distension on Organs at Risk Doses in PDR 3D Image-guided Brachytherapy of Cervical Cancer

Institut de Cancérologie de Lorraine2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2015年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
2
主要终点
Demonstrate the non inferiority of 3D image-guided brachytherapy with emptied bladder compared to filled bladder for the dose received by the bladder

研究概览

简要总结

The purpose of this study is to compare, for each patient, dosimetry of organs at risk (bladder, rectum, sigmoid, small bowel) in two bladder distension procedures (emptied by a urinary catheter or filled with 120cc) during PDR 3D image-guided brachytherapy of cervical cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age > or = 18 years old
  • with a cervical cancer histologically proven (squamous cell carcinoma, adenocarcinoma and neuroendocrine cell carcinoma)
  • Utero-vaginal brachytherapy indications::
  • Stage 1B1: brachytherapy before surgery
  • Stages IB2 to IIIB: after pelvic radiotherapy (45Gy/25 fractions/5 weeks) with or without concomitant chemotherapy
  • Ability to provide an informed written consent form
  • Patient must be affiliated to a social security system

排除标准

  • Age < 18 years old
  • History of pelvic radiotherapy
  • History of pelvic surgery
  • Recent joint prothesis (<3 months)
  • Pregnant woman or being breastfeeding
  • Patients deprived of liberty or under supervision

结局指标

主要结局

Demonstrate the non inferiority of 3D image-guided brachytherapy with emptied bladder compared to filled bladder for the dose received by the bladder

时间窗: 1 day

Difference of the maximum dose received by 2 cm3 bladder (D2cc) between the two conditions: full and empty.

次要结局

  • Non-inferiority based on the dose received by the rectum(1 day)
  • Non-inferiority based on the dose received by the small bowel(1 day)
  • Body Mass Index(1 day)
  • Non-inferiority based on the dose received by the sigmoid(1 day)
  • FIGO staging system(1 day)

研究者

发起方
Institut de Cancérologie de Lorraine
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验